Literature DB >> 7674232

Cardiovascular mortality in women with rheumatoid arthritis.

R Myllykangas-Luosujärvi1, K Aho, H Kautiainen, H Isomäki.   

Abstract

OBJECTIVE: To investigate the relationship of deaths from cardiovascular causes in mortality of women with rheumatoid arthritis (RA). There is increasing evidence that subjects with RA have increased mortality from cardiovascular causes, but little is known of its determinants.
METHODS: Our study included all women subjects in Finland who died during 1989 and who were entitled to reimbursement for medication for RA under the national health insurance plan. Demographic data on the Finnish population and health insurance statistics were used for computations.
RESULTS: Half of the 1186 deaths of women were due to cardiovascular causes. The distribution of specific diagnoses within this disease group did not differ appreciably from that in the female population as a whole. However, there was a 34% excess of deaths due to cardiovascular causes. The median age at death in women with RA was 2.5 years lower than that in the whole population with deaths due to cardiovascular causes.
CONCLUSION: Deaths due to cardiovascular causes constitute and important determinant in the surplus of mortality associated with RA in women.

Entities:  

Mesh:

Year:  1995        PMID: 7674232

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  35 in total

1.  Inflammation-mediated rheumatic diseases and atherosclerosis.

Authors:  S Manzi; M C Wasko
Journal:  Ann Rheum Dis       Date:  2000-05       Impact factor: 19.103

2.  Common carotid intima-media thickness and von Willebrand factor serum levels in rheumatoid arthritis female patients without cardiovascular risk factors.

Authors:  Leonel Daza; Martin Aguirre; Martin Jimenez; Rafael Herrera; J J Bollain
Journal:  Clin Rheumatol       Date:  2006-06-07       Impact factor: 2.980

3.  Severe extra-articular disease manifestations are associated with an increased risk of first ever cardiovascular events in patients with rheumatoid arthritis.

Authors:  C Turesson; R L McClelland; T J H Christianson; E L Matteson
Journal:  Ann Rheum Dis       Date:  2006-07-28       Impact factor: 19.103

Review 4.  Cardiac involvement in systemic autoimmune diseases.

Authors:  Piersandro Riboldi; Maria Gerosa; Cristina Luzzana; Luca Catelli
Journal:  Clin Rev Allergy Immunol       Date:  2002-12       Impact factor: 8.667

5.  Nitric Oxide: Link between Inflammation and Endothelial Dysfunction in Rheumatoid Arthritis.

Authors:  Nidhi Garg; Ashit Syngle; Pawan Krishan
Journal:  Int J Angiol       Date:  2016-12-15

6.  Excess recurrent cardiac events in rheumatoid arthritis patients with acute coronary syndrome.

Authors:  K M J Douglas; A V Pace; G J Treharne; A Saratzis; P Nightingale; N Erb; M J Banks; G D Kitas
Journal:  Ann Rheum Dis       Date:  2005-08-03       Impact factor: 19.103

7.  Despite increased plasma concentration, inflammation reduces potency of calcium channel antagonists due to lower binding to the rat heart.

Authors:  Saeed Sattari; William F Dryden; Lise A Eliot; Fakhreddin Jamali
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

Review 8.  Atherosclerosis in autoimmune rheumatic diseases-mechanisms and clinical findings.

Authors:  Hasya Zinger; Yaniv Sherer; Yehuda Shoenfeld
Journal:  Clin Rev Allergy Immunol       Date:  2009-08       Impact factor: 8.667

9.  Extra-articular disease manifestations in rheumatoid arthritis: incidence trends and risk factors over 46 years.

Authors:  C Turesson; W M O'Fallon; C S Crowson; S E Gabriel; E L Matteson
Journal:  Ann Rheum Dis       Date:  2003-08       Impact factor: 19.103

10.  Change of the aortic elasticity in rheumatoid arthritis: Relationship to associated cardiovascular risk factors.

Authors:  Hamdy Sliem; Gamela Nasr
Journal:  J Cardiovasc Dis Res       Date:  2010-07
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.